EFG Asset Management Americas Corp. Acquires Shares of 26,601 Doximity, Inc. $DOCS

EFG Asset Management Americas Corp. purchased a new stake in shares of Doximity, Inc. (NASDAQ:DOCS) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 26,601 shares of the company’s stock, valued at approximately $1,632,000.

A number of other large investors have also recently made changes to their positions in DOCS. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Doximity by 130.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after purchasing an additional 1,113,076 shares during the period. Vanguard Group Inc. boosted its position in shares of Doximity by 8.8% in the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after acquiring an additional 990,923 shares during the period. Invesco Ltd. grew its stake in Doximity by 54.8% during the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock valued at $114,280,000 after acquiring an additional 696,923 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Doximity by 13.8% during the 2nd quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock worth $320,158,000 after acquiring an additional 634,927 shares during the period. Finally, Nuveen LLC purchased a new stake in Doximity in the 1st quarter worth approximately $34,056,000. 87.19% of the stock is owned by institutional investors.

Doximity Stock Performance

Shares of DOCS opened at $47.95 on Thursday. Doximity, Inc. has a fifty-two week low of $46.38 and a fifty-two week high of $85.21. The firm’s 50-day simple moving average is $66.26 and its two-hundred day simple moving average is $62.28. The stock has a market cap of $9.03 billion, a PE ratio of 47.95, a price-to-earnings-growth ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.30 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Equities research analysts predict that Doximity, Inc. will post 0.99 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on DOCS shares. JPMorgan Chase & Co. reaffirmed an “underweight” rating and issued a $62.00 price target on shares of Doximity in a report on Friday, October 10th. Bank of America raised shares of Doximity from a “neutral” rating to a “buy” rating and upped their price objective for the company from $75.00 to $82.00 in a research note on Monday, October 27th. Piper Sandler lifted their price target on Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. BMO Capital Markets started coverage on shares of Doximity in a research report on Thursday, November 13th. They issued a “market perform” rating and a $55.00 price objective on the stock. Finally, Wells Fargo & Company boosted their price objective on shares of Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $68.78.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total value of $132,880.00. Following the sale, the director directly owned 19,839 shares of the company’s stock, valued at approximately $1,318,103.16. The trade was a 9.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total value of $1,500,000.00. Following the transaction, the director owned 3,221 shares of the company’s stock, valued at $241,575. The trade was a 86.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 32,000 shares of company stock worth $2,339,580. 31.30% of the stock is owned by insiders.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.